OpenVSafe by OpenVAERS
Search V-safe

WS4-24894-86721

2 vaccinations 4 coded responses 13 check-ins 4 free-text entries 0 call cases
Sex
Male
Age at first dose
05-11
ZIP prefix
214 / MD
Registered
2021-11-13
Relationship
Child or adolescent in my care
Guardian
6QQ-24759-26651
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-11
    Dose 1 — Pfizer-BioNTech
  2. 2021-11-13
    Registered in v-safe
  3. 2021-11-13
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-11-14
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  5. 2021-11-15
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  6. 2021-11-18
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  7. 2021-11-25
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  8. 2021-12-03
    Dose 2 — Pfizer-BioNTech
  9. 2021-12-18
    Survey response — day 14, dose 2, dependent
    MedDRA: Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Congestion; fever
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-12-24
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  11. 2021-12-31
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  12. 2022-01-09
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  13. 2022-01-16
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  14. 2022-03-05
    Survey response — 3 months, dose 2, dependent
    MedDRA: Cough, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Cough & fever
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-06-03
    Survey response — 6 months, dose 2, dependent
    MedDRA: Nasopharyngitis, Pre-existing disease — Feeling: Good · Be unable to work or attend school
    Free text: Allergies, cold
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-12-03
    Survey response — 12 months, dose 2, dependent
    MedDRA: Cough, Nasopharyngitis — Feeling: Good
    Free text: Cold with cough
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-11-11Pfizer-BioNTech No
22021-12-03Pfizer-BioNTech No

Free text

Release 10 — day 14, dose 2, dependent

2021-12-18

Symptoms: Congestion; fever

Release 11 — 3 months, dose 2, dependent

2022-03-05

Symptoms: Cough & fever

Release 11 — 6 months, dose 2, dependent

2022-06-03

Symptoms: Allergies, cold

Release 12 — 12 months, dose 2, dependent

2022-12-03

Symptoms: Cold with cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDNasopharyngitis · · ✓
SDPre-existing disease · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release